BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3983886)

  • 1. Adverse reactions to piperacillin in adults with cystic fibrosis.
    Stead RJ; Kennedy HG; Hodson ME; Batten JC
    Thorax; 1985 Mar; 40(3):184-6. PubMed ID: 3983886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
    Michalsen H; Bergan T
    Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE; Høiby N
    Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory infections: clinical evaluation.
    Grassi C
    Clin Ther; 1985; 7 Suppl A():45-54. PubMed ID: 3907845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to piperacillin in cystic fibrosis.
    Stead RJ; Kennedy HG; Hodson ME; Batten JC
    Lancet; 1984 Apr; 1(8381):857-8. PubMed ID: 6143174
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins.
    Lang R; Lishner M; Ravid M
    Rev Infect Dis; 1991; 13(1):68-72. PubMed ID: 2017635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
    Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
    Penketh A; Hodson ME; Gaya H; Batten JC
    Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions to piperacillin in patients with cystic fibrosis.
    Strandvik B
    Lancet; 1984 Jun; 1(8390):1362. PubMed ID: 6145065
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
    Huang NN; Palmer J; Keith H; Schidlow D; Braverman S; Goldberg M
    J Antimicrob Chemother; 1983 May; 11 Suppl B():205-14. PubMed ID: 6352603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis.
    McCarty JM; Tilden SJ; Black P; Craft JC; Blumer J; Waring W; Halsey NA
    Pediatr Pulmonol; 1988; 4(4):201-4. PubMed ID: 3393383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azlocillin in cystic fibrosis.
    Malmborg AS; Alfredsson H; Strandvik B
    Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
    Gold R; Jin E; Levison H; Isles A; Fleming PC
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():331-6. PubMed ID: 6352638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of carbenicillin in patients with cystic fibrosis.
    Boxerbaum B; Doershuk CF; Matthews LW
    J Infect Dis; 1970 Sep; 122():Suppl:S59-61. PubMed ID: 4990025
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis.
    Hyatt AC; Chipps BE; Kumor KM; Mellits ED; Lietman PS; Rosenstein BJ
    J Pediatr; 1981 Aug; 99(2):307-14. PubMed ID: 7019407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis.
    Penketh AR; Hodson ME; Batten JC
    Br J Dis Chest; 1983 Apr; 77(2):179-84. PubMed ID: 6871085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
    Michalsen H; Bergan T
    Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.